Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Cancer survivorship

Improving long-term outcomes in pediatric low-grade glioma

Nature Cancer volume 5, pages 533–535 (2024)Cite this article

Subjects

Low-grade glioma is a tumor type that affects the central nervous system, with favorable survival outcomes in children and adolescents. A study now provides insights into long-term mortality and morbidity associated with different treatments and demonstrates the multifaceted outcomes of adult survivors of childhood glioma.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Summary of study design and results.

References

  1. Ostrom, Q. T. et al. Neuro. Oncol. 16(suppl .1), x1–x36 (2015).

    Article  PubMed  Google Scholar 

  2. Krishnatry, R. et al. Cancer 122, 1261–1269 (2016).

    Article  PubMed  Google Scholar 

  3. Gnekow, A. K. et al. Neuro. Oncol. 14, 1265–1284 (2012).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. de Blank, P. M. K. et al. Nat. Cancer https://doi.org/10.1038/s43018-024-00733-0 (2024).

    Article  PubMed  Google Scholar 

  5. Merchant, T. E., Conklin, H. M., Wu, S., Lustig, R. H. & Xiong, X. J. Clin. Oncol. 27, 3691–3697 (2009).

    Article  PubMed  PubMed Central  Google Scholar 

  6. Williams, N. L. et al. Am. J. Clin. Oncol. Cancer Clin. Trials 41, 307–312 (2018).

    Article  Google Scholar 

  7. Traunwieser, T. et al. Neuro-Oncol. Adv. 2, vdaa094 (2020).

    Article  Google Scholar 

  8. Yamanaka, R., Hayano, A. & Kanayama, T. Neurosurg.l Rev. 41, 719–731 (2018).

    Article  Google Scholar 

  9. Ajithkumar, T., Taylor, R. & Kortmann, R. D. Clin. Oncol. 31, 151–161 (2019).

    Article  CAS  Google Scholar 

  10. Ryall, S. et al. Cancer Cell 37, 569–583.e5 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Miklja, Z. et al. Neuro. Oncol. 21, 968–980 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Hargrave, D. R. et al. Clin. Cancer Res. 25, 7303–7311 (2019).

    Article  CAS  PubMed  Google Scholar 

  13. Bouffet, E. et al. N. Engl. J. Med. 389, 1108–1120 (2023).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics and Adolescent Medicine, Comprehensive Center for Pediatrics and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria

    Johannes Gojo

  2. Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria

    Matthias Preusser

Authors
  1. Johannes Gojo
    View author publications

    Search author on:PubMed Google Scholar

  2. Matthias Preusser
    View author publications

    Search author on:PubMed Google Scholar

Corresponding authors

Correspondence to Johannes Gojo or Matthias Preusser.

Ethics declarations

Competing interests

M.P. has received honoraria for lectures, consultation or advisory board participation from the following for-profit companies: Bayer, Bristol-Myers Squibb, Novartis, Gerson Lehrman Group (GLG), CMC Contrast, GlaxoSmithKline, Mundipharma, Roche, BMJ Journals, MedMedia, Astra Zeneca, AbbVie, Lilly, Medahead, Daiichi Sankyo, Sanofi, Merck Sharp & Dome, Tocagen, Adastra, Gan & Lee Pharmaceuticals, Janssen, Servier, Miltenyi, Böhringer-Ingelheim, Telix and Medscape. J.G. has received honoraria for lectures, consultation or advisory board participation from the following for-profit companies: Novartis and Roche.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gojo, J., Preusser, M. Improving long-term outcomes in pediatric low-grade glioma. Nat Cancer 5, 533–535 (2024). https://doi.org/10.1038/s43018-024-00741-0

Download citation

  • Published:

  • Version of record:

  • Issue date:

  • DOI: https://doi.org/10.1038/s43018-024-00741-0

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing